Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

AC Immune (ACIU) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for AC Immune (ACIU) over the last 9 years, with Q3 2025 value amounting to 0.87%.

  • AC Immune's Return on Capital Employed fell 6000.0% to 0.87% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87%, marking a year-over-year decrease of 6000.0%. This contributed to the annual value of 0.5% for FY2024, which is 5000.0% down from last year.
  • As of Q3 2025, AC Immune's Return on Capital Employed stood at 0.87%, which was down 6000.0% from 0.51% recorded in Q2 2025.
  • In the past 5 years, AC Immune's Return on Capital Employed registered a high of 0.01% during Q1 2021, and its lowest value of 0.87% during Q3 2025.
  • For the 5-year period, AC Immune's Return on Capital Employed averaged around 0.33%, with its median value being 0.39% (2022).
  • In the last 5 years, AC Immune's Return on Capital Employed soared by 3900bps in 2023 and then crashed by -6000bps in 2025.
  • Over the past 5 years, AC Immune's Return on Capital Employed (Quarter) stood at 0.0% in 2021, then crashed by -9824bps to 0.39% in 2022, then surged by 101bps to 0.0% in 2023, then crashed by -9623bps to 0.37% in 2024, then crashed by -132bps to 0.87% in 2025.
  • Its Return on Capital Employed stands at 0.87% for Q3 2025, versus 0.51% for Q2 2025 and 0.41% for Q1 2025.